Emily earned her Master of Science in Neurobiology from Boston University, where she conducted research in the Neurovascular Imaging Laboratory. Her work focused on understanding how neurovascular dynamics are influenced by cell-type-specific neural activity and neuromodulator release in mouse models.

She currently works as a clinical research coordinator, contributing to clinical trials investigating cerebral amyloid angiopathy (CAA) and amyloid-related imaging abnormalities (ARIA).

In her free time, Emily enjoys knitting, bird watching, and swimming.